Send us an emailLonza
COMPANY DETAILS
Muenchensteinerstrasse 38
Basel
4002
Switzerland
+41 61 316 8111
HEALTH CATEGORIES
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. As an integrated solutions provider, Lonza is boosting its value creation along and beyond the healthcare continuum with a strong focus on patient healthcare, consumer preventive healthcare and consumer's healthy environment.
Lonza harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life. With the recent Capsugel acquisition, Lonza now offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries.
Benefiting from its regulatory expertise, Lonza is able to transfer its know-how from pharma to hygiene and fast-moving consumer goods all the way to coatings and composites and the preservation and protection of agricultural goods and other natural resources.
Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 100 sites and offices and approximately 14,500 full-time employees worldwide. The company generated sales of CHF 5.1 billion in 2017 with a CORE EBITDA of CHF 1.3 billion. Further information can be found at www.lonza.com.
Additional Information and Disclaimer
Lonza Group Ltd has its headquarters in Basel, Switzerland, and is listed on the SIX Swiss Exchange. It has a secondary listing on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza Group Ltd is not subject to the SGX-ST’s continuing listing requirements but remains subject to Rules 217 and 751 of the SGX-ST Listing Manual.
Certain matters discussed in this news release may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this news release due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this news release.
NUTRITION & HEALTH NEWS
08 Sep 2023 --- Consumers are continually prioritizing digestive health. As more consumers recognize that this is an area of health they would like to address, more research is being done into how... Read More
NUTRITION & HEALTH NEWS
03 Aug 2023 --- The demand for fiber and protein is at its highest, with food formulators being inventive in incorporating this type of carbohydrate into products. Another significant development... Read More
NUTRITION & HEALTH NEWS
31 Jul 2023 --- The importance of lifelong joint health is becoming increasingly evident to consumers, impacting their fitness goals and overall mobility. Backed by over ten human clinical studies... Read More
NUTRITION & HEALTH NEWS
29 Jun 2023 --- The sports nutrition sector experienced a 9% growth in product launches from 2021 to 2022, according to Innova Market Insights. Industry professionals see opportunities to expand... Read More
NUTRITION & HEALTH NEWS
20 Apr 2023 --- Consumers increasingly recognize that all aspects of health are interlinked, leading to a growing demand for products with multiple claims and benefits. Experts highlight that... Read More
20 Jun 2022 --- TWK10® sports probiotic is an innovative strain L. plantarum and is the first probiotic clinically proven to increase exercise endurance by up to 75% in athletes of all levels. Learn how TWK10® sports probiotic can help you break through in the competitive global sports and active nutrition categories.This Video is from Lonza.
16 May 2022 --- Amid toughening regulations surrounding titanium dioxide (TiO2) as a whitening ingredient, Lonza is expanding its Capsugel offering to meet TiO2-free requirements for food supplements in the EU. The company’s global product manager Julien Lamps details the opportunities and challenges surrounding the opacifying technology.
15 Mar 2022 --- In light of the EU’s ban on titanium dioxide, Anne Holderbach explores Lonza’s alternatives for capsules, which use iron oxide for an opaque effect and moderate UV protection. In terms of more vivid semi-opaque options, the company has also developed food-colored capsules.
31 May 2021 --- The “unharmonized” probiotics scene contributes to consumer confusion, which has motivated Chr. Hansen to launch a global online version of The Probiotics Institute. The one-stop-shop educational platform helps consumers navigate the “probiotics jungle” and demystify the human microbiome. Linda Neckmar, VP of commercial development, details why the company has developed a separate version for the Chinese market and how the move coincides with wider company strategies.
22 Dec 2020 --- General health with an emphasis on digestion is set to reach new heights over the coming years as new research emerges, according to Roel van de Put, Lonza Capsules and Health Ingredients’ business development manager. Beauty-from-within, mobility, mood health and immunity will also be major forces shaping the nutritional realm, he predicts.
05 Dec 2022 --- For supplement and nutraceutical brands, there’s no better time to seize the booming joint health market opportunity. Download Lonza’s NEW eBook to discover what consumers want, and how to capture market share and consumer attention in the dynamic joint health category with UC-II® undenatured type II collagen.This Technical Paper is from Lonza.
19 Apr 2022 --- TWK10® sports probiotic is an innovative strain L. plantarum and is the first probiotic clinically proven to increase exercise endurance by up to 75% in athletes of all levels.Learn how TWK10® sports probiotic can help you break through in the competitive global sports and active nutrition categories.This Technical Paper is from Lonza.
Consumers are increasingly looking for plant-based offerings and supplements are no exception. Plant-based or vegan claims on supplements grew by 34 percent between 2015 and 2019 and show no... Read More
While differing generations have unique nutritional priorities, they share a desire to live healthy and less stressed lives. This has led many to turn to supplements as an easy way to... Read More
Clean label remains king in the supplement space, as consumers who are wary of ingredient traceability and safety are drawn to shorter label lists. Concerns from consumers and lobby groups... Read More
The aging consumer has growing expectations of bone and joint health solutions, thanks to the mainstreaming of sports nutrition and a growing focus on active aging. According to Innova... Read More
Products featuring bone & joint health claims are on the rise, with Innova Market Insights data showing a compound annual growth rate of 13 percent between 2013 and... Read More
16 Aug 2023 --- In this episode, we speak with Emily Navarro, Lonza’s global product marketing manager for nutrition products and services, and Amy Sunderman, the company’s director of R&D for ingredients regarding the potential for Lonza’s UC-II ingredient in the functional food and beverage sector in light of a new benchtop study, which demonstrated its retention under different processing and manufacturing conditions.
21 Feb 2022 --- Today’s NewsBite Podcast details Lonza’s sports probiotic launching in the EU. DSM announced two of its probiotic strains received New Dietary Ingredient status from the FDA, while Calocurb is developing its hop extract Amarasate into a functional food additive that can help suppress appetite.
07 Jun 2021 --- This NewsBite podcast delves into Chr. Hansen and Lonza’s joint venture, Bacthera, receiving manufacturing licenses to start supplying live biotherapeutic products. Meanwhile, Probi partnered on probiotic research for vaginal health NPD targeting the “underserved” market. Also, a Safefood report revealed that online conversations about healthy diets are missing input from health experts.
15 Feb 2021 --- During the last week, Evolve BioSystems landed US$55 million for the commercialization of its “next generation of probiotic.” Other top stories include Lonza’s US$4.7 billion sale of its Speciality Ingredients business and Kappa Bioscience’s US expansion of its vitamin K2 production.
25 Jan 2021 --- This week’s NutritionInsight NewsBite podcast looks into e-gaming’s emerging market potential. Recent business news highlights include Lonza’s exit from the softgel arena in the pharma market and other moves in the infant formula sector.
12 Sep 2023 --- Pre, Pro and Postbiotics have gained popularity in the EMEA region for their potential to improve digestive health, boost immunity, and enhance overall well-being. However, formulating and delivering them effectively to ensure their maximum efficacy remains a significant challenge. Brands have to innovate to create new and efficient supplements for microbiome health that stand out from competition. In this webinar Nick Morgan will present the current market trends in the microbiome field and the hottest segments. Zoltan Szepesi will highlight the different innovative solutions the Capsugel® dosage forms can offer to optimize the Pre, Pro and Postbiotic delivery and solve your technical challenges. Discover Lonza Capsule & Health Ingredients’ ready-to-go product concepts to launch your next innovation quickly.
25 Apr 2023 --- Discover the science behind UC-II® undenatured type II collagen and why not all collagens are created equal. Our experts will introduce our product concepts and show the flexibility of dosage forms from powder filled capsule to liquid-filled capsules & gummies. Sirio & Lonza developed two concepts with UC-II® in gummies and Sirio experts will show the innovative properties of these new products.
17 Aug 2022 --- Esports is one of the fastest-growing segments in the nutrition market. With nearly three billion active gamers globally, the time is now for brands to deliver innovative new products to professional esports gamers and fans alike.
05 Nov 2020 --- For today’s health-conscious and responsible consumers, Lonza’s Capsugel Plantcaps capsules provide the premier balance of product performance and convenience. This webinar dives into the latest market trends, as well as the science and regulatory landscape surrounding Plantcaps.
24 Jun 2020 --- Supplement users increasingly aspire to more sustainable, health-focused ideals and are on the hunt for high-quality, responsibly sourced products that help them to stay mobile and live better. In this webinar, Lonza experts delve into how these preferences extend across a range of emerging, on-demand consumer trends, from joint and cognitive health to probiotics and beauty-from-within.
